The Pharmaceutical Market: India

Date: January 31, 2013
Pages: 117
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P15298F7990EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: India
OVERVIEW OF THE PHARMACEUTICAL MARKET IN INDIA

The outlook for India's patented drug market is not promising. The primary reason why sales of these products will not grow swiftly is the country's intellectual property (IP) regime, which is well below international standards. It does not recognise incremental improvements and as such few medicines receive exclusivity. The outlook is also restricted by the government's apparent desire to spend as little as possible on medical services. Whileprudenceis virtuous in an indebted global economy, India still needs to spend the 'market rate' for healthcare infrastructure, doctors, nurses, medical devices and innovative pharmaceuticals. Without the necessary therapeutics, healthcare rofessionals, hospitals andclinics, India's healthcare indicators will not improve as desired by the authoritiesand, more importantly,bypatients and their families.

Headline Expenditure Projections

Pharmaceuticals: INR730.0bn (US$15.6bn) in 2011 to INR839.4bn (US$15.7bn) in 2012; +15.0% in local currency terms and +0.3% in US dollar terms. Our US dollar forecast is significantly lower than in Q312 due to weakening of the rupee.

Healthcare: INR3,353.7bn (US$71.9bn) in 2011 to INR3,746.3bn (US$70.0bn) in 2012; +11.7% in local currency terms and -2.6% in US dollar terms. Our US dollar forecast is significantly lower than in Q312 due to weakening of the rupee.

Medical devices: INR138.9bn (US$3.0bn) in 2011 to INR153.3bn (US$2.9bn) in 2012; +10.4% in local currency terms and -3.7% in US dollar terms. Our US dollar forecast is significantly lower than in Q312 due to weakening of the rupee.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
BMI INDUSTRY VIEW

SWOT

POLITICAL

ECONOMIC

BUSINESS ENVIRONMENT

INDUSTRY FORECAST

OVERALL MARKET FORECAST

   Table: Pharmaceutical Sales, 2009-2017
   Table: Total Healthcare Expenditure, 2009-2017
   Table: Governmental Healthcare Expenditure, 2009-2017
   Table: Private Healthcare Expenditure, 2009-2017

ECONOMIC ANALYSIS

PRESCRIPTION DRUG/PATENTED

   Table: Prescription Drug Sales, 2009-2017
   Table: Patented Drug Sales, 2009-2017

PATENTED DRUG MARKET FORECAST

   Table: Patented Drug Sales, 2009-2017

GENERICS

   Table: Table: Generic Drug Sales, 2009-2017

OTC

   Table: Table: OTC Medicine Sales, 2009-2017

EXPORT/IMPORT

   Table: Table: Pharmaceutical Trade, 2009-2017

MEDICAL DEVICES TRADE

   Table: Table: Medical Device Sales, 2009-2017

OTHER HEALTHCARE

INDUSTRY RISK REWARD RATINGS

   Table: Table: Asia Pacific Pharmaceuticals And Healthcare Risk/Reward Ratings, Q113
  Rewards
  Risks

MARKET OVERVIEW

INDUSTRY TRENDS AND DEVELOPMENTS

  Epidemiology
  Healthcare Sector
  Healthcare Funding
  Healthcare Insurance
  Research & Development
    India Pharmaceuticals & Healthcare Report Q1 2013
   Table: R&D EXPENDITURE IN TOP 20 INDIAN PHARMACEUTICAL FIRMS (BY MARKET CAPITALISATION)
  Clinical Trials
  Foreign Direct Investment
  Biosimilars
   Table: LIST OF SELECTED BIOSIMILARS DEVELOPED BY INDIAN PHARMACEUTICAL FIRMS
  Traditional Medicines

REGULATORY DEVELOPMENT

  Regulatory Environment
   Table: Department Of Pharmaceuticals' Responsibilities
  Pharmaceutical Advertising
  Pharmacovigilance
  Intellectual Property Regime
   Table: History Of The Indian Patent System
  Pricing Policy
  Compulsory Licences

COMPETITIVE LANDSCAPE

  Government Provision Of Pharmaceuticals74
  Key Pharmaceuticals And Healthcare Industry Developments
  Production
  Wholesale
  Retail

COMPANY PROFILE

CIPLA

RANBAXY

DR. REDDY

AUROBINDO

PFIZER

GSK

NOVARTIS

SANOFI

MERCK & CO

DEMOGRAPHIC FORECAST

   Table: India's Population By Age Group, 1990-2020 ('000)
   Table: India's Population By Age Group, 1990-2020 (% of total)
   Table: India's Key Population Ratios, 1990-2020
   Table: India's Rural And Urban Population, 1990-2020

GLOSSARY

METHODOLOGY

METHODOLOGY

  Risk/Reward Ratings Methodology

RATINGS OVERVIEW

TABLE: PHARMACEUTICAL BUSINESS ENVIRONMENT INDICATORS

WEIGHTING

TABLE: WEIGHTING OF COMPONENTS

SOURCES
Skip to top


Looking at Offshoring in the Pharmaceutical Industry US$ 300.00 Jun, 2011 · 50 pages
The Pharmaceutical Market: Singapore US$ 1,295.00 Jan, 2013 · 112 pages
The Pharmaceutical Market: Croatia US$ 1,295.00 Jan, 2013 · 86 pages
The Pharmaceutical Market: Cuba US$ 1,295.00 Mar, 2013

Ask Your Question

The Pharmaceutical Market: India
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: